A call for transparent reporting to optimize the predictive value of preclinical research

[1]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[2]  O. Steward,et al.  Replication and reproducibility in spinal cord injury research , 2012, Experimental Neurology.

[3]  Iain Chalmers,et al.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO , 2011, Journal of the Royal Society of Medicine.

[4]  Leif D. Nelson,et al.  False-Positive Psychology , 2011, Psychological science.

[5]  M. Macleod,et al.  Preclinical studies of human disease: time to take methodological quality seriously. , 2011, Journal of molecular and cellular cardiology.

[6]  F. Prinz,et al.  Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.

[7]  Iveta Simera,et al.  Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.

[8]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[9]  M. Macleod,et al.  Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis. , 2011, Parkinsonism & related disorders.

[10]  Z. Dienes.  Bayesian Versus Orthodox Statistics: Which Side Are You On? , 2011, Perspectives on psychological science : a journal of the Association for Psychological Science.

[11]  R. Bausell,et al.  Application of Consolidated Standards of Reporting Trials (Consort) , 2011 .

[12]  Kenneth R. Hess,et al.  Statistical design considerations in animal studies published recently in cancer research. , 2011, Cancer research.

[13]  M. Macleod,et al.  Improving the translational hit of experimental treatments in multiple sclerosis , 2010, Multiple sclerosis.

[14]  David W Howells,et al.  Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-Analysis , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  J. Gallo,et al.  Pharmacokinetic/ pharmacodynamic-driven drug development. , 2010, The Mount Sinai journal of medicine, New York.

[16]  D. Howells,et al.  A Systematic Review and Meta-Analysis of Erythropoietin in Experimental Stroke , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  D. Fanelli.  Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data , 2010, PloS one.

[18]  D. Fanelli.  “Positive” Results Increase Down the Hierarchy of the Sciences , 2010, PloS one.

[19]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.

[20]  D. Howells,et al.  Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy , 2010, PLoS biology.

[21]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[22]  D. Moher,et al.  CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials , 2010, PLoS medicine.

[23]  F. Song,et al.  Dissemination and publication of research findings: an updated review of related biases. , 2010, Health technology assessment.

[24]  Stanley E Lazic,et al.  The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis? , 2010, BMC Neuroscience.

[25]  Albert C. Ludolph,et al.  Guidelines for preclinical animal research in ALS/MND: A consensus meeting , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[26]  I. Cuthill,et al.  Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals , 2009, PloS one.

[27]  Marc Fisher,et al.  Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations , 2009, Stroke.

[28]  U. Dirnagl,et al.  Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality , 2008, Stroke.

[29]  Iveta Simera,et al.  Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research , 2008, BMC medicine.

[30]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[31]  U. Dirnagl,et al.  Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach , 2008, Stroke.

[32]  H. MacPherson,et al.  A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture Trials , 2008, PloS one.

[33]  J. E. Kranz,et al.  Design, power, and interpretation of studies in the standard murine model of ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[34]  M. Macleod,et al.  A Systematic Review and Meta-Analysis of the Efficacy of Piracetam and Piracetam-Like Compounds in Experimental Stroke , 2007, Cerebrovascular Diseases.

[35]  I. Cuthill,et al.  Effect size, confidence interval and statistical significance: a practical guide for biologists , 2007, Biological reviews of the Cambridge Philosophical Society.

[36]  John P A Ioannidis,et al.  Almost all articles on cancer prognostic markers report statistically significant results. , 2007, European journal of cancer.

[37]  Malcolm Macleod,et al.  How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.

[38]  E. Unger,et al.  All is not well in the world of translational research. , 2007, Journal of the American College of Cardiology.

[39]  J. Hilden,et al.  Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. , 2007, International journal of epidemiology.

[40]  Robert L Kane,et al.  Reporting in randomized clinical trials improved after adoption of the CONSORT statement. , 2007, Journal of clinical epidemiology.

[41]  D. Redelmeier,et al.  Translation of research evidence from animals to humans. , 2006, JAMA.

[42]  Jeffrey M Jonas,et al.  Pharmacotherapy and behavioral intervention for alcohol dependence. , 2006, JAMA.

[43]  D. Moher,et al.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.

[44]  S. Rockwell,et al.  Publishing Negative Results: The Problem of Publication Bias , 2006, Radiation research.

[45]  Louette R. Johnson Lutjens.  Research , 2006 .

[46]  J. Ioannidis,et al.  Why Most Published Research Findings Are False , 2005, PLoS medicine.

[47]  G. Donnan,et al.  Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  G. Donnan,et al.  Systematic review and meta‐analysis of the efficacy of melatonin in experimental stroke , 2005, Journal of pineal research.

[49]  David W Howells,et al.  Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias , 2004, Stroke.

[50]  Kennon Heard,et al.  Emergency medicine animal research: does use of randomization and blinding affect the results? , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[51]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2003, Clinical Oral Investigations.

[52]  D. Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[53]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.

[54]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[55]  M A Waclawiw,et al.  Practical guidelines for multiplicity adjustment in clinical trials. , 2000, Controlled clinical trials.

[56]  Stroke Therapy Academic Industry Roundtable.  Recommendations for standards regarding preclinical neuroprotective and restorative drug development. , 1999, Stroke.

[57]  R. Wears,et al.  Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting. , 1998, JAMA.

[58]  R. Horton.  CONSORT , 1996, The Lancet.

[59]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[60]  H. Khamis,et al.  A Problem in Statistical Analysis: Simultaneous Inference , 1991 .

[61]  S. Pocock,et al.  Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.

[62]  T C Chalmers,et al.  Bias in treatment assignment in controlled clinical trials. , 1983, The New England journal of medicine.

[63]  R. Rosenthal.  The file drawer problem and tolerance for null results , 1979 .

[64]  T. Sterling.  Publication Decisions and their Possible Effects on Inferences Drawn from Tests of Significance—or Vice Versa , 1959 .

[65]  D. Moher,et al.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.

[66]  C. G. Begley,et al.  Raise standards for preclinical cancer research , 2012 .

[67]  Yan Zhang,et al.  A systematic review and meta-analysis , 2012 .

[68]  D. Fanelli.  Negative results are disappearing from most disciplines and countries , 2011, Scientometrics.

[69]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[70]  Shimin Liu.  Dealing with publication bias in translational stroke research. , 2009, Journal of experimental stroke & translational medicine.

[71]  R. Bausell,et al.  Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). , 2008, Nursing outlook.

[72]  M. Festing.  Design and statistical methods in studies using animal models of development. , 2006, ILAR journal.

[73]  Douglas G Altman,et al.  Guidelines for the design and statistical analysis of experiments using laboratory animals. , 2002, ILAR journal.

[74]  Kimberly Scearce-Levie,et al.  Animal Models of Alzheimer's Disease: Modeling Targets, Not Disease Accelerating Drug Discovery for Alzheimer's Disease: Best Practices for Preclinical Animal Studies , 2022 .